Search

Displaying results 8171 - 8180 of 10000 in total
  1. Drug

    Tanimilast

    go.drugbank.com/drugs/DB12800
    Investigational

    CHF6001 has been used in trials studying the treatment of Asthma and Chronic Obstructive Pulmonary Disease.

  2. Drug

    BK-MDA

    go.drugbank.com/drugs/DB12809
    Investigational

    BK-MDA has been used in trials studying the treatment of Bladder Exstrophy and Urinary Incontinence.

  3. Drug

    Pradigastat

    go.drugbank.com/drugs/DB12866
    Investigational

    Pradigastat has been used in trials studying the treatment of Non-alcoholic Fatty Liver Disease (NAFLD).

    Categories: Heterocyclic Compounds, 1-Ring
  4. Drug

    Namodenoson

    go.drugbank.com/drugs/DB12885
    Investigational

    Namodenoson has been used in trials studying the treatment of Chronic Hepatitis C and Hepatocellular Carcinoma.

    Categories: Heterocyclic Compounds, 2-RingSynonyms: 2-Chloro-N(6)-(3-iodobenzyl)adenosine-5'-N-methyluronamide
  5. Drug

    Dimiracetam

    go.drugbank.com/drugs/DB13018
    Investigational

    Dimiracetam has been used in trials studying the treatment of AIDS, Neuropathy, and Acquired Immunodeficiency Syndrome.

    Categories: Heterocyclic Compounds, 1-Ring
  6. Drug

    Lanifibranor

    go.drugbank.com/drugs/DB14801
    Investigational

    Lanifibranor is under investigation in clinical trial NCT03008070 (Phase 2b Study in NASH to Assess IVA337).

    Categories: Heterocyclic Compounds, 1-Ring, Heterocyclic Compounds, 2-Ring
  7. Drug

    Konjac mannan

    go.drugbank.com/drugs/DB14963
    Investigational

    Konjac mannan is under investigation in clinical trial NCT01709955 (The Effects of Glucomannan on Weight Loss).

    Products: BIBRALIGHT©.
  8. Drug

    Suvratoxumab

    go.drugbank.com/drugs/DB15172
    Investigational

    Suvratoxumab is under investigation in clinical trial NCT02296320 (Study of the Efficacy and Safety of MEDI4893).

  9. Drug

    Suvodirsen

    go.drugbank.com/drugs/DB17940
    Investigational

    Suvodirsen is an antisense oligonucleotide that has been investigated for the treatment of Duchenne muscular dystrophy.

  10. Drug

    ART5803

    go.drugbank.com/drugs/DB18379
    Investigational

    ART5803 is a humanized one-armed monoclonal antibody with a high affinity for the NMDA receptor.